Skip to main content

Imaging of intestinal vasculitis focusing on MR and CT enterography: a two-way street between radiologic findings and clinical data


Diagnosis of intestinal vasculitis is often challenging due to the non-specific clinical and imaging findings. Vasculitides with gastrointestinal (GI) manifestations are rare, but their diagnosis holds immense significance as late or missed recognition can result in high mortality rates. Given the resemblance of radiologic findings with some other entities, GI vasculitis is often overlooked on small bowel studies done using computed tomography/magnetic resonance enterography (CTE/MRE). Hereon, we reviewed radiologic findings of vasculitis with gastrointestinal involvement on CTE and MRE. The variety of findings on MRE/CTE depend upon the size of the involved vessels. Signs of intestinal ischemia, e.g., mural thickening, submucosal edema, mural hyperenhancement, and restricted diffusion on diffusion-weighted imaging, are common in intestinal vasculitis. Involvement of the abdominal aorta and the major visceral arteries is presented as concentric mural thickening, transmural calcification, luminal stenosis, occlusion, aneurysmal changes, and collateral vessels. Such findings can be observed particularly in large- and medium-vessel vasculitis. The presence of extra-intestinal findings, including within the liver, kidneys, or spleen in the form of focal areas of infarction or heterogeneous enhancement due to microvascular involvement, can be another radiologic clue in diagnosis of vasculitis. The link between the clinical/laboratory findings and MRE/CTE abnormalities needs to be corresponded when it comes to the diagnosis of intestinal vasculitis.

Key points

  • While gastrointestinal presentations are uncommon in vasculitis, their timely diagnosis is critical.

  • Patients may present with a wide variety of non-specific findings on MRE/CTE.

  • Extraintestinal findings are useful that should be covered in the MRE/CTE field.

  • Imaging features need to be linked with the clinical and laboratory data.


Vasculitis is a term used for a heterogeneous group of conditions resulting in inflammation and injury of blood vessels in a variety of organs [1]. While this condition is rare, it can potentially have fatal outcomes due to resulting necrosis and ischemia. Therefore, there would be a need for early diagnosis and therapeutic interventions. Due to the non-specific clinical and imaging findings, diagnosis of vasculitis is often challenging. This is due to its similarities with other conditions, such as infections, malignancies, connective tissue diseases, and thromboembolic disorders [2,3,4]. A clinical history of systemic diseases, along with constitutional symptoms, including fever, weight loss, and fatigue, and most importantly, a dramatic response to immunosuppressive therapy could suggest a potential diagnosis of vasculitis.

A wide variety of vasculitides can present with abdominal manifestations, which could be the first presentation of a systemic disease [4,5,6]. While vasculitis of the gastrointestinal (GI) tract is rare, its diagnosis holds immense significance as late or missed recognition can result in high morbidity and mortality rates [5]. Abdominal pain, nausea, vomiting, diarrhea, GI bleeding (commonly presented as occult blood in stool, hematochezia, melena, and hematemesis), and weight loss are the most common GI presentations. Rarely, patients may develop serious complications, including intestinal perforation, ischemia, or peritonitis [7]. The wide spectrum of clinical and imaging findings in vasculitis, which may be non-specific and overlapping with other conditions, raises a diagnostic challenge.

Patients with vasculitis of the GI tract may undergo computed tomography/magnetic resonance enterography (CTE/MRE) to assess intestinal pathologies responsible for the non-specific clinical manifestations [7]. In addition to intestinal findings, CTE and MRE can often detect extra-intestinal pathologies [8,9,10]. The most common radiographic features in the GI tract, seen in different types and various stages of vasculitis, are submucosal edema or hemorrhage, mesenteric edema, bowel dilatation, and findings of acute or chronic mesenteric ischemia. Eventually, the ischemia may result in bowel perforation or stricture [4, 11].

Given the resemblance of radiologic findings with other entities such as infection, inflammatory bowel disease (IBD), and mesenteric ischemia secondary to vascular thromboembolism, diagnosis of vasculitis is often overlooked on MRE or CTE [12]. It is a diagnostic challenge and could not be simply differentiated from other disorders based on imaging findings alone. Therefore, a multidisciplinary team approach and histopathologic analysis are often required to make a definitive diagnosis. Radiologists must be aware of the diverse imaging patterns in intestinal vasculitis since they might be the first caregivers suggesting the proper diagnosis preventing misdiagnosis [12]. To the best of our knowledge, there is no comprehensive review describing the imaging characteristics of intestinal vasculitis on MRE/CTE.

Herein, we present radiologic findings of GI vasculitis with a focus on CTE and MRE by representative clinical cases. We highlight the diagnostic clues in clinical features and laboratory findings, helping in establishing the diagnosis. Lastly, a practical algorithm is provided to assist in the diagnosis of intestinal vasculitis and to differentiate it from other common GI disorders.

Classification of vasculitis: an overview

Vasculitides are classified as (1) primary (idiopathic), with most likely autoimmune causes, and (2) secondary, which can stem from malignancy, infection, connective tissue diseases, drugs, or environmental exposures. The revised Chapel Hill Consensus Conference nomenclature system classifies vasculitides primarily according to the predominant type of vessel involvement and etiology. The classification is into seven categories: large-, medium-, small-, and variable-vessel vasculitis, single-organ vasculitis, vasculitis associated with systemic disease, and vasculitis associated with probable etiology (Fig. 1) [13]. Clinical presentation and imaging features are typically related to the size and location of involved vessels and the extent of the disease.

Fig. 1
figure 1

Diagram of various types of vasculitis based on the size of the affected vessel and etiology

While the exact pathophysiology of vasculitis is not elucidated, the inflammation caused by infiltration of immune cells (lymphocytes, neutrophils, and monocytes/macrophages) in different layers of the vessel walls, release of pro-inflammatory cytokines, deposition of immune complexes, or presence of auto-antibodies can trigger vascular injury. Subsequent to the inflammation, conditions such as stenosis, occlusion, and rarely aneurysms can develop within the vessel (Fig. 2). Aneurysms commonly result from the destruction of the media layer and are associated with a risk of spontaneous hemorrhage and mural thrombosis. Obliteration or stenosis of the arterial lumen leads to decreased perfusion in abdominal organs, and in case vasa vasorum is involved, it can result in intestinal ischemia. Furthermore, diffuse intimal calcification may occur as a result of chronic vascular inflammation [14].

Fig. 2
figure 2

Schematic illustration on the spectrum of vasculitis related damage on the vessel wall

Technical considerations

The 2017 consensus statement of joint European Society of Gastrointestinal and Abdominal Radiology (ESGAR) and European Society of Pediatric Radiology (ESPR) describes routine technical considerations for cross-sectional small bowel and colonic imaging [15]. Three main additional technical points should be incorporated into the routine MRE and CTE protocols when intestinal vasculitis is suspected:

(a) Arterial phase should be added to the routine post-contrast portal or enteric phase, which enhances visualization of arterial structures and vasculitis-associated intestinal ischemia [16, 17];

(b) As concurrent involvement of solid abdominal organs may be the only key to distinguish intestinal vasculitis from other entities, it is important to expand the field of scan as far as possible to cover extra-intestinal organs while avoiding a drop in image quality.

Large-vessel vasculitis

Large-vessel vasculitides predominantly involve the great vessels, such as the aorta and its major branches. Takayasu arteritis and giant cell arteritis (GCA) are the most prevalent vasculitis in this subgroup. Considering the lack of specific diagnostic biomarkers, imaging modalities, including Doppler ultrasound, CT or MR angiography, digital subtraction angiography, and 18F-fluorodeoxyglucose positron emission tomography (PET), play a crucial role in diagnosing large-vessel vasculitis [1, 18, 19]. GI involvement is far more common in Takayasu arteritis than GCA. Radiologic features may be similar to mesenteric ischemia caused by thromboembolism or non-occlusive causes [20, 21]. The other differential diagnoses include atherosclerosis, connective tissue disorders, such as Marfan syndrome, Ehlers–Danlos syndrome, and Loeys–Dietz syndrome [12, 22].

Takayasu arteritis

Takayasu arteritis is an autoimmune-mediated granulomatous inflammation of the aorta, its major branches, and pulmonary arteries, most commonly affecting young Asian women [23]. Lesions are typically close to the origin of the primary aortic branch [24]. At the disease onset or during acute phases, the presentations can be non-specific, including malaise, fever, weight loss, anorexia, myalgia, or arthralgias. Abdominal pain was observed in approximately 16% of patients [25]. However, more characteristic signs and symptoms develop with disease progression, including reduced or absent peripheral pulses, arterial bruits, limb claudication, blood pressure discrepancies between the arms due to stenotic or occlusive lesions, and hypertension [23].

GI involvement is rare in Takayasu arteritis. The intestine, spleen, and, rarely, the liver may undergo ischemic changes due to stenosis or occlusion of large- and medium-size GI arteries [6, 25]. Notably, in a cohort of 79 patients with Takayasu, only one patient developed mesenteric ischemia [25]. Approximately one-third of patients have involvement of the abdominal aorta or mesenteric circulation [26]. Kermani et al., in a cohort of 125 patients with Takayasu, found involvement of the abdominal aorta, mesenteric artery, and renal arteries in imaging of approximately 38%, 35%, and 20% of the patients, respectively [27]. The vascular involvements included arterial stenosis, thrombosis, and, rarely, aneurysms. Aortic dissection is very rare, and less than ten cases have been reported involving the abdominal aorta [28]. Notably, several studies have reported a higher prevalence of IBD among patients with Takayasu arteritis with evidence of genetic overlap [29, 30].

The intestinal findings on the CTE/MRE may include segmental intestinal circumferential mural thickening, abnormal wall enhancement, and submucosal edema. The edema and enhancement reduce dramatically following corticosteroid treatment. Ischemic changes caused by vasculitis can be manifested by a diffuse long segment GI involvement [25]. Bowel dilation and mesenteric vascular engorgement are among other GI findings [12]. Extra-intestinal findings may include concentric mural thickening, transmural calcification, luminal stenosis, occlusion, aneurysmal changes, and collateral vessels formation in the abdominal aorta and its major branches, such as the celiac and superior mesenteric arteries. These vascular pathologies can also be seen on other cross-sectional imaging modalities. On contrast-enhanced CT, arterial mural enhancement can be found during the arterial phase, which is intensified during the late phase. However, since the measurement of mural enhancement may be hindered by the overshining intravascular contrast material, the black blood MRI technique is recommended for early detection of vessel wall inflammation [24]. Following contrast administration, the intima is poorly enhanced while the media-adventitia layer is intensely enhanced, resulting in a “double-ring” enhancement pattern (Fig. 3) [24, 31,32,33]. The possibility of underlying Takayasu arteritis should be considered when mural thickening or irregularity of the aorta and main branches is seen in younger age patients. Intestinal involvement in this disease may only cause a non-specific bowel wall thickening. Rapid response of bowel abnormality to steroid treatment which can be confirmed in follow-up imaging is a potential diagnostic clue.

Fig. 3
figure 3

Intestinal vasculitis in a 35-year-old female with known Takayasu arteritis presenting with RLQ pain and elevated ESR. Axial contrast-enhanced CT scan (A) shows mural thickening and severe stenosis at the origin of the celiac artery (thin black arrow). Axial CT image (B) demonstrates circumferential mural thickening and submucosal edema at a single distal ileal segment (elbow arrow). MRE (C) was done following corticosteroid therapy after six days. Axial T2-W image shows complete resolution of corresponding ileal involvement (thick white arrow). Axial post-contrast T1-W image (D) displays concentric and irregular mural thickening and enhancement of abdominal aorta (black dotted oval) with double rings appearance (inner low and outer high enhancement). MR angiography (E) was performed. MIP image shows irregularity and multi-segmental stenosis at the distal abdominal aorta (thin white arrows). There is also bilateral stenosis at the origin of renal arteries (white arrowheads). The proximal segment of SMA shows irregularity and severe stenosis (white dotted oval). Abnormal dilatation of the arc of Riolan (white curved arrows) is evident, which supplies collateral flow to the SMA territory

Giant cell arteritis

Giant cell arteritis (GCA) is a granulomatous vasculitis with a higher prevalence among women older than 50 and patients of northern European descent. GCA has a higher tendency to involve carotid, vertebral, and temporal arteries [34]. The disease manifestations include new-onset headache, jaw claudication, visual loss, constitutional symptoms, anorexia, and polymyalgia.

Abdominal involvement is extremely rare in GCA, especially when compared with Takayasu arteritis [35]. Kermani et al. reported mesenteric artery, abdominal aorta, and renal artery lesions in 17%, 6%, and 10% of patients, respectively [27]. So far, fewer than 15 cases of mesenteric ischemia have been reported [6], some with obstruction and infarction of the small intestine [36] or infarction of the sigmoid colon [37]. The abdominal aorta was involved in nearly half of GCA patients with aortitis, with approximately one-third presenting with abdominal pain [38]. Nevertheless, a recent longitudinal study found that abdominal aorta dilation in GCA was comparable to controls [39]. Acute abdominal pain in patients with GCA, which usually develops 6–7 years after disease onset, might also be an alarming sign for aneurysm or dissection [6, 40]. Strikingly, we did not identify any investigation on MRE or CTE findings of GCA in the literature.

Medium-vessel vasculitis

Medium-sized vessels, mainly splanchnic arteries and their branches, are predominantly involved in medium-vessel vasculitis. The onset of vasculitis in medium vessels is more acute and necrotizing than in large-vessel [1]. This group includes polyarteritis nodosa and Kawasaki disease. GI involvement is more common in polyarteritis nodosa, with up to 95% of patients presenting with abdominal pain [1]. Radiologic findings include discovery of microaneurysms, arterial stenosis/occlusion, signs of intestinal ischemia, bleeding or perforation, rupture of hepatic, splenic, and/or renal (micro-)aneurysms, and rarely segmental hepatic or splenic infarction. Conventional angiography is the most reliable imaging technique utilized to investigate splanchnic vascular abnormalities [41, 42].

Polyarteritis nodosa

Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis affecting medium and small vessels like in the kidneys without glomerulonephritis. It can occur in patients of any age, gender, or ethnicity; however, the peak incidence is at the 5th–6th decade of life. It involves the kidneys, skin, musculoskeletal system, nerves, and GI system [43]. The inflammation commonly affects all layers of vessels, resulting in stenosis, occlusion, or aneurysm. Therefore, tissue ischemia or hemorrhage may be observed in various organs, leading to acute life-threatening complications. Theoretically, histological confirmation of segmental fibrinoid necrosis of medium-sized vessels is required for the diagnosis. Nevertheless, the diagnosis can also be established based on clinical, laboratory (absence of antineutrophil cytoplasmic antibody (ANCA)), and radiologic findings. Angiography is the preferred imaging modality for detecting microaneurysm formations in visceral arteries [1, 43, 44].

PAN can cause heterogeneous GI manifestations, with non-specific abdominal pain occurring in 35–95% of the patients [4, 6, 11]. Other GI presentations are nausea, vomiting, diarrhea, gastroduodenal ulcers (mainly in the jejunum), hematochezia, hematemesis, and melena. Mesenteric vasculitis is observed in 50–60% of patients, which can lead to GI ischemia [26] or (rarely) aneurysm formation [45]. Serious abdominal complications include GI bleeding caused by ischemic mucosal ulcerations, bowel infarct or perforation, as well as perforation of microaneurysms, and organ ischemia due to visceral artery involvement [6, 46]. The severe manifestations rarely develop (< 5%) and can be a predictor of high mortality [11, 46]. Intestinal ischemia has even been reported as the initial presentation of the systemic disease [47]. PAN is the most common systemic vasculitis associated with gallbladder disease, with nearly 4% of patients developing cholecystitis [11]. While hepatic and splenic complications are rare, the patients may experience occlusion of hepatic veins (Budd–Chiari syndrome) and segmental liver or spleen ischemia [6, 7].

The intestinal findings on CTE/MRE include segmental bowel mural thickening, submucosal edema, and abnormal hyperenhancement with striated pattern (Fig. 4). The involved intestinal region may also show diffusion restriction on DWI sequence. Luminal stenosis, mural irregularity and thickening, and aneurysmal dilation can be detected in visceral arteries, especially in the superior mesenteric artery (SMA) branches (Fig. 5). Visceral infarction and ruptured aneurysm may also be observed on contrast-enhanced CT [26, 48]. While microaneurysms (of renal, mesenteric, and/or splenic arteries) are the hallmark of PAN, they are not often directly detectable on enterography [49]. However, heterogeneous liver enhancement can indicate microvascular abnormalities (Fig. 4). Besides, the addition of an arterial phase in the imaging protocol may improve the detection of the microaneurysms. Since the kidney is the most commonly affected organ, its end-organ damage can present as striated nephrogram indicating renal infarct [49, 50]. Hydronephrosis resulting from detrusor muscle spasm is another urinary system complication [4, 51].

Fig. 4
figure 4

Intestinal vasculitis in a 32-year-old female with PAN (polyarteritis nodosa) presenting with episodic abdominal pain, fever, anemia, and elevated liver enzymes and inflammatory markers. MRE was obtained. Coronal and axial T2-W images (A, B) show a single thickened segment of mid ileum (thick white arrows) with mild T2 hyperintensity more likely secondary to submucosal edema. This is associated with mild degree of upstream bowel distention. Coronal and axial post-contrast T1-W images (C, D) display mural hyperenhancement (thin white arrows) with a relatively striated pattern. DWI at a b-value of 800 s/mm2 (E) shows restricted diffusion (white arrowhead), suggesting increased inflammatory cell density. The patient underwent double-balloon enteroscopy following this MRE, but it was complicated by bowel perforation at this segment. Then, surgical resection and ileostomy were performed. Histopathological assessment of resected segment revealed vasculitis consistent with polyarteritis nodosa (PAN). Heterogeneous enhancement of liver at arterial phase is also depicted (C), which raises suspicion for microvascular involvement (white dotted oval)

Fig. 5
figure 5

Vasculitis of splanchnic arteries in a 43-year-old male with a history of pathologically proven polyarteritis nodosa and segmental jejunal resection due to ischemia. He complains of postprandial abdominal pain, nausea, vomiting, hypertension, and elevated inflammatory markers. CTE was done. Axial and sagittal images (AC) in the arterial phase demonstrate severe stenosis at the origin of the celiac trunk (thin white arrows) and complete occlusion and irregularity of proximal SMA (thin black arrows). Coronal CT images (DF) reveal vessel irregularity and mild degree of aneurysmal dilations in a collateral branch between celiac trunk and SMA (white arrowheads), thickening and irregularity in jejunal branches of SMA (black dotted oval) adjacent to the previous site of jejunal resection and anastomosis (white curved arrows). The ileocolic branch of SMA also shows focal aneurysmal dilatation and mild thickening (white dotted oval)

Differential diagnoses of splanchnic vascular abnormalities in PAN include segmental arterial mediolysis (SAM), fibromuscular dysplasia (FMD), and mycotic aneurysm. Intestinal involvement in PAN may mimic other inflammatory conditions like Crohn's disease (CD). A clinical history of underlying systemic disorders, a dramatic response to immunosuppressive therapy, and most importantly abnormalities of visceral arteries could suggest a potential diagnosis of vasculitis. In the absence of bowel abnormality, involvement of branch points in mesenteric vessels and sparing of the main renal artery are useful clues to distinguish vasculitis from SAM and FMD, respectively. In a young patient with clinical manifestation of mesenteric ischemia, a thorough inspection of visceral arteries should be done in the arterial phase of CTE/MRE to find segmental arterial wall thickening, stenosis, or aneurysmal dilatation, especially in the presence of constitutional symptoms, elevated levels of inflammatory markers showing a systemic inflammatory response (such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)). It is important to exclude vasculitis when mesenteric ischemia is not located in the classic watershed territory of bowel ischemia.

Kawasaki disease

Kawasaki disease is a self-limiting acute necrotizing vasculitis affecting the medium and small vessels in almost all organs. Infants and children under five years of age and of Asian ethnicity are most commonly affected. Adults are scarcely affected, and they commonly have incomplete forms of the disease. GI manifestations include abdominal pain and/or distension, vomiting, diarrhea, paralytic ileus, jaundice, hepatomegaly, gallbladder hydrops, and, far less frequently, serious complications such as pancreatitis, GI obstruction, or pseudo-obstruction [6, 52,53,54]. In the largest series of patients with adult-onset Kawasaki disease, 56% had GI manifestations [55]. Presentation of GI involvement can be associated with a poor prognosis [52]. Notably, we did not identify any investigation on MRE or CTE features in Kawasaki disease.

Small-vessel vasculitis

Small-vessel vasculitis predominantly involves small intraparenchymal vessels. This group based on pathogenesis is classified into two sub-groups; (1) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and (2) immune complex-associated vasculitis. Current imaging techniques due to limited resolution are unable to directly visualize small-vessel vasculitis. Consequently, imaging is used to assess the damaging effects on affected organs [56, 57]. Common findings on CTE/MRE include intestinal submucosal edema or hemorrhage, mesenteric edema, bowel dilatation, mesenteric fat haziness, and findings of acute or chronic mesenteric ischemia. Rarely, bowel perforation or stricture may occur as a consequence of inflammation. Differential diagnoses based on imaging include non-occlusive mesenteric ischemia, infectious enteritis, eosinophilic enteritis, IBD, radiation, and chemotherapy-induced enteritis.

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) can occur at any age and includes granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis [58]. While AAV is a small-vessel vasculitis, it may cause inflammation of medium-sized vessels as well. A wide variety of organs, including the respiratory system, kidneys, nervous system, and GI tract, can be involved in AAV [59].

Granulomatosis with polyangiitis (Wegener's granulomatosis)

Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis of small- and medium-sized vessels with granulomatosis, which involves the upper and lower respiratory tracts and the kidneys. The condition is most common in the fourth or fifth decade of life [60]. Imaging can aid in determining the extent of disease, including pulmonary involvement [44]. The most common imaging findings in GPA are multiple and bilateral pulmonary nodules or masses [31, 61].

GI manifestations are present in 5–11% of patients with GPA. While any part of the GI tract might be involved, the abnormalities are commonly seen in the small and large bowel [6, 62]. GI manifestations include abdominal pain, ulceration (oral, esophageal, peptic, and intestinal), bloody diarrhea, peritonitis, and hematochezia. Rarely, patients may develop severe life-threatening intestinal involvement, including ischemia and perforation [6, 63]. Prolonged immunosuppressive treatment is postulated as the primary underlying risk factor for intestinal necrosis and perforation [63, 64]. The severe manifestations typically develop in patients with extensive involvement of the other organs shortly after the diagnosis and initiating the immunosuppressive therapy [63, 64]. Other rare abdominal complications of GPA may include granulomatous colitis, granulomatous pancreatic mass, splenic or hepatic infarct or hemorrhage, and gastritis [6, 65, 66].

Multi-focal segmental circumferential mural thickening and abnormal hyperenhancement of the small and/or the large intestine can be detected on MRE/CTE (Fig. 6). Mesenteric vascular engorgement or unexpected large-vessel pathology (i.e., stenosis or dilation) and ascites can be observed as well [4, 51, 67]. Mesenteric fat haziness is another occasional finding, which stems from inflammation of the mesenteric vessels. In patients presenting with acute abdominal pain, signs of bowel perforation and/or necrosis, including focal intestinal pneumatosis and mild ascites, can be present. However, it should be noted that the immunosuppressive treatment might mask acute symptoms of intestinal ischemia (Fig. 6). The presence of pathologies in the kidneys can be a valuable diagnostic clue. Wedge-shaped T2-weighted hyperintensities and hypoenhancing lesions at the renal parenchyma with diffusion restriction on DWI are potential findings that can imply interstitial nephritis or renal ischemia (Fig. 7). Splenic involvement, including splenomegaly and splenic infarction, can also be detected [51]. In patients with bowel pathologies, concurrent abnormal laboratory results or imaging findings related to pulmonary or renal involvement and positive c-ANCA titer are helpful clues to differentiate GPA from other disorders (Fig. 8).

Fig. 6
figure 6

Intestinal vasculitis and perforation in a 56-year-old male with known ANCA-positive granulomatosis with polyangiitis and long history of immunosuppressive therapy presenting with acute abdominal pain and leukocytosis. Chest X-ray (A) shows two pulmonary nodules projecting over the lower zone of the left hemithorax (black dotted ovals). MRE was obtained. Axial T2-W image (B) reveals multi-focal segmental mural thickening in jejunal loops (thin black arrows). Axial post-contrast T1-W image (C) displays intense mural hyperenhancement (thin white arrows) in the involved segments. Focal intestinal pneumatosis (white dotted ovals) is also evident. Axial T2-W image (D) shows pneumoperitoneum (white arrowheads) at the non-dependent portion of the abdominal cavity, indicating bowel perforation. Coronal T2-W image (E) demonstrates small amount of free fluid (thick white arrows) at the abdominal cavity. Due to acute nature of presentation, the patient subsequently underwent laparotomy. Intraoperative photograph (F) reveals focal bowel necrosis and perforation. No signs of peritonitis were found in the initial examination, more likely due to the immunocompromised status of the patient

Fig. 7
figure 7

Intestinal vasculitis in a 39-year-old female presenting with episodic abdominal pain and findings of non-specific terminal ileitis in ileocolonoscopy examination. MRE was obtained. Coronal T2-W and post-contrast T1-W images (A, B) display mild mural thickening and hyperenhancement at distal terminal ileum (thick white arrows). Coronal T2-W and post-contrast T1-W images (C, D) reveal multiple peripheral wedge-shaped hyperintense areas at both kidneys, showing decreased enhancement on delayed phase (white arrowheads). Axial post-contrast T1-W and corresponding DWI images (E, F) show a hypoenhancing lesion at the right renal cortex with diffusion restriction (thin white arrows). Vasculitis was suspected as the underlying cause. Afterward, positive results for antineutrophil cytoplasmic antibody (ANCA) and inflammatory markers were consistent with the diagnosis of ANCA-associated vasculitis

Fig. 8
figure 8

Intestinal vasculitis and pulmonary alveolar hemorrhage in a 41-year-old male with ANCA-positive granulomatosis with polyangiitis (GPA) presenting with abdominal pain and hemoptysis. Axial thoracic CT images (A, B) at two different levels show diffuse mosaic attenuation secondary to geographic areas of ground-glass opacity, suggestive for alveolar hemorrhage. Follow-up CT images (C, D) three days after corticosteroid therapy demonstrate a notable response to treatment. CTE was also done with suboptimal small bowel distention (E, F) at admission to assess the cause of abdominal pain that revealed circumferential mural thickening at ascending colon and distal ileum (thin white arrows) associated with adjacent mesenteric fat haziness. Follow-up CT images (G, H) show complete response to corticosteroid therapy with normal bowel wall thickness (thick white arrows) and a decrease in attenuation of the ileocolic mesenteric root

Microscopic polyangiitis

Microscopic polyangiitis (MPA) (also known as leukocytoclastic vasculitis) is a systemic autoimmune non-granulomatous vasculitis of the small vessels associated with the presence of ANCA, with a slightly higher prevalence in men [68]. Similar to PGA, kidneys and lungs are the primary organs that are involved. However, skin lesions (commonly present as palpable purpura), neurological manifestations, and GI involvement may also occur.

GI involvement is observed in 5–30% of the patients [6, 68]. Abdominal pain is the most frequent GI presentation, associated with nausea, vomiting, and diarrhea. Lower GI bleeding and ischemia are rare but life-threatening complications [46, 68,69,70], which can scarcely result in massive hemorrhage [71].

Radiologic features of bowel involvement are similar to other small-vessel vasculitides [4]. Correspondingly, intestinal concentric mural thickening and post-contrast hyperenhancement can be detected on enterography (Fig. 9). Engorgement of adjacent mesenteric vessels is one of the other potential findings. In acute cases, signs of bowel infarction or perforation can be rarely observed [4]. Similar to GPA, the presence of extra-intestinal renal and pulmonary pathologies can be an important diagnostic clue. Cutaneous lesions, including palpable purpura, especially on the extremities, may be the key clinical feature of leukocytoclastic vasculitis compared to similar conditions.

Fig. 9
figure 9

Intestinal vasculitis in a 28-year-old male with leukocytoclastic vasculitis presenting with abdominal pain, chest discomfort, and erythematous rashes with palpable purpura on the lower extremities. An abdominopelvic CT scan with IV and oral contrast was obtained. Axial images (A, B) show mild bilateral pleural effusion and pelvic free fluid. Also, axial CT (C) demonstrates mild concentric mural thickening of the distal ileal loop (thin black arrows). The patient underwent a biopsy of skin lesions. The histopathologic study revealed leukocytoclastic vasculitis. Corticosteroid therapy started. Then, MRE was done after five days. Axial post-contrast T1-W images (D, E) display mild mural thickening and hyperenhancement (thick white arrows) in the distal ileal segments. Mild engorgement of adjacent mesenteric vessels (white dotted oval) is also evident, and there is no ascites. Imaging findings and clinical data were indicative of an excellent response to therapy

Eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

Eosinophilic granulomatosis with polyangiitis (EPGA) is a necrotizing granulomatous small-vessel vasculitis characterized by adult-onset asthma and tissue eosinophilia. Patients can be divided into two groups: (1) ANCA-positive patients (30–40%) with predominant vasculitis manifestations, and (2) ANCA-negative patients with predominant eosinophilic presentations [72]. The most common signs and symptoms include asthma, lung infiltrates, neuropathy, and constitutional symptoms, while cardiac, skin, renal, and GI involvement are less frequent [72].

GI presentations can be observed in 30–50% of patients, including abdominal pain, diarrhea, melena, and hematochezia. No significant difference is found in the frequency of GI manifestations between ANCA-positive and ANCA-negative patients [72]. Vasculitis of the mesenteric artery is the most prevalent cause of GI involvement, resulting in bowel ischemia. Mucosal eosinophilic infiltration can be another underlying cause of ulceration, motility disorders, and obstructive symptoms [6]. Mucosal ulcers, which are typically limited to the small intestine, can be detected by endoscopy [72]. Severe complications, including bowel obstruction and stenosis, can occur in 22–45% of the patients [72]. Hepatobiliary complications are infrequent and include cholestasis and liver infarction [73,74,75]. The potential underlying causes of hepatic involvement are fibrinoid necrosis of arteries, eosinophilic infiltration, and granulomatous reaction in the portal area. These conditions may be seen in addition to the irregular narrowing of the small hepatic arteries, which can be detected by angiography [74].

On MRE, intestinal mural hyperenhancement can be delineated, which may or may not be associated with mural thickening (Fig. 10) [76]. Mural hyperenhancement can also be evident on CT images [72], which occurs as a result of mesenteric vasculitis or mucosal eosinophilic infiltrations [4]. Submucosal edema causes a striated bowel wall appearance with diffuse mucosal enhancement manifesting as a halo sign [51]. Signs of severe complications include bowel obstruction and stenosis [77,78,79], and as a result, bowel dilatation is a frequent CT finding [72]. Hepatic infarction may present as multiple wedge-shaped areas of hypoattenuation. Moreover, signs of eosinophilic abscess, such as intraparenchymal gas and fluid formation, may also be evident [80]. Approximately 70% of patients with EGPA present with pulmonary involvement, such as patchy, transient, and non-segmental opacities that have no predilection for any lung zone. Since intestinal vasculitis related to EGPA could only present as increased wall enhancement on MRE/CTE without gross mural thickening, attention should be paid beyond the GI tract searching for important clues such as infarction of the visceral organs or lung involvement, particularly in patients with a history of asthma and eosinophilia [81].

Fig. 10
figure 10

Intestinal vasculitis and perforation in a 32-year-old male with a history of asthma presenting with abdominal pain and eosinophilia. MRE was obtained. Coronal and axial post-contrast T1-W images (A, B) display increased mural enhancement at the terminal ileum without thickening (thick white arrows). Three months later (C, D), the patient presents to the ER with acute abdominal pain without definite diagnosis or treatment. Chest X-ray (C) shows subdiaphragmatic free gas (thick black arrow). He underwent an emergency laparotomy. Intraoperative photograph (D) revealed focal bowel perforation at the distal ileal segment. After segmental bowel resection, an ileostomy was performed. Eight months after surgery (E, F), he was admitted for RUQ pain and dyspnea. Axial chest CT image (E) demonstrates bilateral GGO and consolidations with lobular distribution (white dotted oval). Axial contrast-enhanced CT image (F) shows multiple wedge-shaped areas of hypoattenuation in the liver (thin white arrows), consistent with hepatic infarction. Intraparenchymal gas formation is also evident at the infarcted segment, suggestive for abscess formation (black dotted oval). Small-vessel vasculitis was confirmed based on clinical/laboratory data and pathology results suggestive of Churg–Strauss syndrome. Unfortunately, he died secondary to sepsis

Immune complex-associated vasculitis

Similar to AAV, medium-sized vessels can be involved in addition to small vessels in immune complex-associated vasculitis. Activation of complements by the immune complexes leads to the attraction of neutrophils to the vessel wall and subsequently inflammation and vascular lesion. Radiologic findings are similar to other small-vessel vasculitides. This group includes immunoglobulin (Ig) A vasculitis and cryoglobulinemic vasculitis.

IgA vasculitis (Henoch–Schönlein purpura)

IgA vasculitis, formerly called Henoch–Schönlein purpura (HSP), is a systemic, leukocytoclastic vasculitis affecting small vessels. Being the most common vasculitis in children, IgA vasculitis in adulthood is less prevalent than in childhood. While the etiology is not well understood, genetic and environmental factors play a major role in disease pathogenesis. The most common manifestations are palpable purpura, arthralgia and/or arthritis, glomerulonephritis, and acute enteritis [82].

GI involvement can be observed in approximately two-thirds of patients. Abdominal pain is the most common GI presentation, followed by nausea, vomiting, melena, and/or rectorrhagia [83]. In 40–50% of the patients, the mesenteric circulation is involved [26]. Rarely (3–5%) patients may experience serious complications, including bowel infarct, perforation [84], obstruction, or irreducible intussusception [85]. Intestinal ischemia can even be the initial manifestation of the disease (29). Seldom (< 5%) the hepatobiliary system can be involved as well [86].

On imaging, signs of bowel ischemia and edema can be observed, including segmental mural thickening and post-contrast focal mural hypoenhancement (Fig. 11). However, hemorrhage is commonly limited to mucosa and submucosa and is self-limiting [4, 87]. Importantly, glucocorticoids, which are used to alleviate clinical symptoms such as arthralgia, can mask pain and signs of bowel ischemia [88]. Descending duodenum and the terminal ileum are frequently involved [89]. Dramatic improvement after corticosteroid therapy is a characteristic feature of GI involvement [89]. Gallbladder wall thickening can also be observed in 25% of those with hepatobiliary involvement [86]. The diagnosis of HSP is mainly based on typical clinical signs and symptoms like skin rash, arthritis, colicky abdominal pain, GI bleeding, and hematuria. Imaging characteristics of the bowel wall are also helpful in diagnosis and management. Based on our clinical experience, while mural hyperdensity in non-contrast CTE images favors submucosal hemorrhage, focal hypoenhancement in post-contrast images suggests ischemic changes or edema associated with inflammation.

Fig. 11
figure 11

Intestinal ischemia in a 37-year-old male with a history of known Henoch–Schönlein purpura (HSP) presenting with abdominal pain and bloody diarrhea. The patient underwent pre (A)- and post (B)-IV contrast CT scans using positive dilute oral contrast. Segmental mural thickening (thick white arrows) is seen in the terminal ileum with a focal area of mural hypoenhancement (thin white arrows) proximal to the ileocecal valve. Ileocolonoscopy confirmed mucosal ischemic changes, and signs/symptoms were improved following treatment by corticosteroid

Cryoglobulinemic vasculitis

Cryoglobulins are abnormal immune system proteins that can deposit in the small vessel walls leading to cryoglobulinemic vasculitis. The skin, kidneys, joints, and peripheral nervous system are commonly involved. Type I cryoglobulinemic vasculitis is usually related to an underlying lymphoproliferative disorder. Types II (monoclonal) and III (polyclonal) are typically associated with rheumatoid factor activity. The main underlying causes of cryoglobulins production include lymphoproliferative disorders, systemic lupus erythematosus (SLE), Sjögren syndrome, and rheumatoid arthritis [90].

GI involvement is rare but can become disastrous. These manifestations include abdominal pain, melena, and more severe complications, such as intestinal perforation, intestinal ischemia, acute cholecystitis, and pancreatitis [91]. Liver involvement can be observed in up to 60% of the patients [6].

Variable-vessel vasculitis

The vasculitis does not have any predominant vessel size or type involvement. This group includes Behçet's disease and Cogan syndrome [13]. In the latter syndrome, only a few cases of mesenteric vasculitis have been reported [92]. The location, extent, and size of the involved vessels determine the radiologic and clinical signs. Differential diagnoses of MRE/CTE findings are non-occlusive mesenteric ischemia, infectious enteritis, eosinophilic enteritis, IBD, radiation enteritis, and chemotherapy-induced enteritis.

Behçet disease

Behçet's disease is a systemic inflammatory vasculitis affecting vessels of all sizes and also multiple organs. Ocular lesions, oral aphthous ulcers, genital ulcers, and skin lesions are the characteristic manifestations, which can be associated with vascular, neurological, and GI involvement. The prevalence of Behçet's disease is higher in the Mediterranean, Middle East, and the Far East regions (along the ancient Silk Route) and is associated with the distribution of HLA-B51. The disease onset is commonly at the third or fourth decades of life [93].

The prevalence of GI manifestations is widely varied in different geographic regions, ranging from 1.4 to 60% [94,95,96]. GI involvement is more frequent in the Far East than in the Middle East and Europe. Abdominal pain, usually in the right lower quadrant, is the most common presentation, followed by diarrhea and GI bleeding [96]. In Behçet's disease, GI complications typically have a relapsing nature [97]. The ileocolic region, including the ileocecal area, ileum, or different colonic segments, is most commonly involved [98, 99]. Bleeding and perforation are among serious complications; however, in chronic cases, closed perforation might develop. Acute lower GI bleeding has been reported in approximately 11–25% of those with GI manifestations, and it might be the initial GI presentation [100, 101]. In addition to intestinal involvement, thrombosis of the hepatic vein or inferior vena cava can result in hepatic complications, particularly Budd–Chiari syndrome. Very rarely, large-vessel involvement might result in the formation of abdominal aorta aneurysms [102].

On imaging, irregular circumferential mural thickening with homogeneous mural enhancement is the most common finding of bowel involvement. Behçet's disease can significantly mimic CD on MRE. Deep penetrating ulcers and restricted diffusion on DWI in the involved segment could also be observed (Fig. 12) [20, 103]. Unlike CD, there is no specific predilection to the mesenteric side in Behçet's disease with less surrounding mesenteric inflammatory changes (Fig. 13). Peker and colleagues reported a specificity of 100% and sensitivity of 57% for polypoid patterns and homogeneous mural enhancement findings in distinguishing Behçet's from CD [104]. While pathologies of more proximal ileal segments favor small bowel CD, ileocecal involvement favors Behçet's disease. Additionally, patients with Behçet's disease may have a shorter length of the involved segment than CD [104]. History of recurrent oral and genital ulcers and uveitis is also important to make the diagnosis. Mural enhancing saccular pseudoaneurysms of the abdominal aorta may also be detected [40].

Fig. 12
figure 12

Terminal ileitis in a 23-year-old female with a history of recurrent oral and genital aphthous ulcers and uveitis presenting with RLQ pain finally diagnosed as Behçet’s disease. MRE was obtained. Coronal and axial T2-W images (A, B) show mural thickening in the terminal ileum (thick white arrows) without significant predilection to the mesenteric side in contrast to Crohn’s disease. There is also a deep penetrating ulcer (thin white arrow). Axial post-contrast T1-W image (C) displays increased contrast enhancement in the thickened terminal ileal segment (white arrowheads) without surrounding mesenteric inflammatory changes. Axial DWI image and corresponding ADC map obtained at b-value of 800 s/mm2 (D, E) show restricted diffusion in the involved segment (white dotted oval). Histopathologic examination confirmed Behçet’s disease

Fig. 13
figure 13

Intestinal vasculitis in a 26-year-old female with known Behçet’s disease and positive HLA-B5 complaining of episodic RLQ pain. MRE was obtained. Coronal T2-W image (A) demonstrates irregular circumferential mural thickening of the cecum and proximal ascending colon (thick black arrows) without mesenteric side predilection or pericolic infiltration. Coronal and axial post-contrast T1-W images (B, C) show marked enhancement of thickened colonic wall (thick white arrows) mildly extending to ileocecal valve (thin white arrow) with low-grade mural hyperenhancement in the adjacent terminal ileum (white arrowhead). Axial DWI image (D) obtained at a b-value of 800 s/mm2 reveals restricted diffusion in the thickened cecum (white dotted oval)

Vasculitis associated with systemic diseases

According to the revised Chapel Hill Consensus Conference nomenclature system, vasculitides secondary to connective tissue and autoimmune diseases are classified as vasculitis associated with systemic diseases [13]. While small vessels are commonly involved, medium and large vessels may also be affected. SLE, rheumatoid arthritis, systemic sclerosis (scleroderma), and antiphospholipid antibody syndrome are among diseases associated with vasculitis that can have concurrent GI involvement [6, 105,106,107].

Systemic lupus erythematosus (SLE)

SLE is a complex systemic disease with a female predominance resulting from immune complex deposition and production of auto-antibodies in various organs. The prevalence of vasculitis in patients with SLE ranges from 11 to 36%. Lupus vasculitis has various clinical manifestations as a result of involving vessels of all sizes [108, 109]. However, small-sized vessels are more frequently affected, and mesenteric vasculitis, also known as lupus enteritis, is far less common, with a prevalence of 0.2% to 9.7%, mostly involving the SMA [110]. SMA involvement can result in ileal and jejunal ischemia [108]. Lupus mesenteric vasculitis commonly presents with acute abdominal pain with diffuse localization [110]. Additionally, thrombosis of the mesenteric arteries may also occur even in the absence of vasculitis [111]. Rarely, GI manifestations, such as intestinal ischemia, can be the initial presentation of the systemic disease [47]. Notably, secondary Sjögren's syndrome may occur in approximately 14%–17.8% of SLE patients (Fig. 14) [112].

Fig. 14
figure 14

Intestinal ischemia in a 31-year-old female with known SLE-Sjögren overlap syndrome presenting with fever, anemia, and LUQ pain. MRE was obtained. Coronal T2-W and post-contrast T1-W images (A, B) display mural thickening, mucosal hypoenhancement, and serosal hyperenhancement of descending colon adjacent to the splenic flexure (thick white arrows) suggestive for mucosal ischemic changes. Coronal T2-W and post-contrast T1-W images (C, D) display mural thickening and increased mural enhancement of the cecum and ascending colon (Thin white arrows). Axial T2-W image and corresponding DWI sequence (E, F) show concentric mural thickening of the proximal ascending colon, demonstrating restricted diffusion (white arrowheads), in favor of ischemic changes or increased inflammatory cells. Coronal post-contrast T1-W image (G) reveals subcapsular areas of splenic hypoenhancement (white dotted oval), indicative of infarction. Pale and fragile mucosa is seen in colonoscopic view (H) of the involved colonic splenic flexure

Imaging is an indispensable tool in the assessment of lupus enteritis. Multi-focal segmental circumferential wall thickening, submucosal edema, and mucosal ischemic changes are among the potential intestinal findings on MRE/CTE. Bowel wall thickening commonly caused by edema can result in a “thumb printing sign” presentation that can be found in bowel ischemia [113, 114]. The diffuse circumferential wall thickening with submucosal edema gives rise to a “target sign” or “double-halo” finding, which can help in distinguishing SLE from other pathologies [115, 116]. The local hypervascular appearance of the adjacent mesentery, often seen in CD, also known as the “Comb sign,” is one of the other findings on CT of patients with lupus enteritis. Collectively, comb sign and/or target signs are present in approximately 70% of the patients with lupus enteritis [117].

The genitourinary system is frequently involved in SLE presenting as hydronephrosis, cystitis, and lupus nephritis, which could be used to reach the diagnosis (Fig. 15). Vasculitis should always be considered in patients with enteritis accompanied by single- or multi-organ infarcts (Fig. 16). Lupus enteritis must be suspected in a young patient with evidence of serositis (pleural effusion, pericardial effusion, or ascites). Imaging appearance of lupus enteritis can mimic CD, although the presence of ascites is not common in CD and should raise suspicion of serositis. Bowel ischemic changes may present mucosal hypoenhancement and serosal hyperenhancement on MRE suggestive for early to intermediate stage bowel ischemia compared to transmural necrosis seen at late-stage ischemia [21]. Similar imaging features might be reported in antiphospholipid antibody syndrome, which is characterized by thrombosis and/or recurrent early pregnancy loss and is highly associated with SLE. However, abdominal vessel thrombosis can be a key diagnostic clue (Fig. 17).

Fig. 15
figure 15

Intestinal vasculitis in a 42-year-old female with a known history of SLE and hypothyroidism presenting with generalized abdominal pain, fever, anemia, and elevated inflammatory markers. She also complained of dysuria, hematuria, and frequency. MRE was obtained. Axial T2-W images (A, B) show bilateral hydroureteronephrosis (thin white arrows) and multi-focal segmental circumferential mural thickening involving several jejunal and ileal loops (thick white arrows). Axial T2-W image (C) displays an under distended urinary bladder containing a Foley catheter showing diffuse wall thickening (thick black arrows). Coronal T2-W and post-contrast T1-W images (D, E) demonstrate multi-segmental mural thickening involving several jejunal and ileal loops showing increased enhancement due to active nature of inflammation (black arrowheads). Submucosal edema is also noted (thin black arrow). Axial T2-W and post-contrast T1-W images (F, G) also reveal involvement of rectosigmoid colon (white dotted ovals). Small amount of free fluid is noted at the abdominopelvic cavity (black asterisks)

Fig. 16
figure 16

Intestinal vasculitis and renal infarction in a 29-year-old female with known SLE presenting with fever, malaise, generalized abdominal pain, dyspnea, and elevated ESR. An abdominopelvic CT scan with IV and oral contrast was done. There are subpleural patchy areas of GGO at the left lower lobe suggestive of lupus pneumonitis (thick black arrows in A). Small pericardial effusion and thickening (thin white arrows in B) are seen in favor of serositis. There is a wedge-shaped subcapsular hypodensity in the spleen (white dotted oval in C), indicative of splenic infarction. Multiple bilateral wedge-shaped renal parenchymal infarcts are also depicted (thick white arrows in D). Diffuse circumferential wall thickening of ileal loops (white arrowheads in E and F) is evident, representing lupus enteritis

Fig. 17
figure 17

Bowel stricture with secondary bacterial overgrowth in a 44-year-old male with a history of primary antiphospholipid antibody syndrome. He presented with abdominal pain, fever, nausea, vomiting, and diarrhea without a history of previous surgery. CTE was obtained. Axial CT (A) shows evidence of chronic SMV thrombosis associated with multiple collateral veins in the mesenteric root (white dotted oval). CT images (BD) demonstrate diffuse mural thickening at jejunal loops with submucosal edema and mucosal hyperenhancement (thick white arrows). There is an abrupt stricture in a segment of proximal ileum (thin white arrows) leading to upstream bowel dilatation (white asterisks) suggestive of partial obstruction with development of ascites. The clinical and imaging findings were suspicious for focal stricture secondary to an old vascular insult with secondary bacterial overgrowth in dilated jejunal and proximal ileal loops. The patient underwent antibiotic therapy, bowel rest, and conservative management resulting in improvement of signs/symptoms. He was discharged with an uneventful follow-up

Systemic sclerosis (Scleroderma)

Systemic sclerosis is an autoimmune disease leading to fibrosis and disfiguration of the skin, along with dysfunctioning lungs, kidneys, heart, and GI tract [118]. Without histopathological investigation, it is difficult to distinguish between systemic sclerosis-related vasculopathy, which is non-inflammatory, and concurrent vasculitis [105]. However, whether due to vasculopathy or vasculitis, GI manifestations are very common in systemic sclerosis, with involvement of the oral cavity, esophagus, stomach, small and large intestine, liver, and pancreas. In nearly 10% of the patients, GI symptoms are the initial presentation of the systemic disease. The small intestine is the second most frequently involved organ, although the majority of patients with intestinal pathologies remain asymptomatic [119].

Small bowel involvement includes stiffness and atrophy of the smooth muscles leading to reduced small bowel mobility, chronic or acute intestinal pseudo-obstruction, small intestinal bacterial overgrowth, pneumatosis cystoides intestinalis, and jejunal diverticula. Smooth muscle atrophy and fibrosis of the intestinal wall with dominant inner circular muscle layer involvement compared to the outer longitudinal layer result in a characteristic finding in systemic sclerosis, namely “hidebound sign,” which is an increased number of bowel folds stacked together in spite of luminal distention without an increase in interfold distance [120]. Intestinal mural thickening with a hypointense appearance on T2-weighted imaging indicates mural fibrosis (Fig. 18). Additionally, asymmetric small bowel wall fibrosis can result in intestinal sacculation, which may present as multiple wide-mouthed outpouchings involving all intestinal wall layers [120]. Diffuse dilation of the small intestine (particularly jejunum) may occur, mainly upstream to the fibrotic bowel strictures. Colonic dilation may develop following acute colonic pseudo-obstruction, also known as Ogilvie syndrome (Fig. 19). Moreover, pneumatosis cystoides intestinalis, defined as air-filled cysts within the intestinal wall, can be detected on enterography. Rupture of these intraluminal cysts can result in benign or sterile pneumoperitoneum.

Fig. 18
figure 18

Intestinal vasculitis and benign intestinal pneumatosis in a 52-year-old male with a history of known Scleroderma presenting with abdominal pain. Physical examination revealed generalized abdominal tenderness without rebound or guarding. Upright CXR (A) was done in the ER. Pneumoperitoneum (thick black arrows) was noted at CXR in the absence of signs or symptoms of peritonitis. Due to this discrepancy, abdominal CT scan (B, C) was performed and confirmed pneumoperitoneum (thin black arrow) along with extensive intestinal pneumatosis in the transverse colon (black arrowheads) and jejunum (thick white arrows). The patient underwent conservative treatment. He was discharged one week later with improved signs/symptoms. After three weeks, MRE was obtained and displayed no pneumoperitoneum. Axial T2-W image (D) demonstrates segmental jejunal mural thickening (white dotted oval) with hypointense appearance. Coronal T2-W image (E) shows bowel dilation and the classic hidebound sign (black dotted oval) in the ileum related to known scleroderma. The T2 hypointense segment of thick jejunum is also seen (curved arrows), suggestive of chronic mural thickening perhaps due to fibrosis

Fig. 19
figure 19

Colonic pseudo-obstruction in a 35-year-old female with known scleroderma presenting with constipation, nausea, vomiting, and abdominal distension. CT scan with IV/oral contrast was done. Axial CT image (A) demonstrates dilation of the distal esophagus (thick white arrows), a common finding in scleroderma. Axial CT image (B) reveals marked diffuse dilatation of colon (*) without obvious wall thickening or abrupt transition point, suggestive for colonic pseudo-obstruction (Ogilvie syndrome)

Subcutaneous calcification is a valuable extra-intestinal finding suggestive of an underlying systemic cause (e.g., scleroderma) for intestinal disease (Fig. 20). Meanwhile, esophageal dilatation and rarely hepatobiliary pathologies (nearly in 1.5% of patients), including hepatic duct obstruction due to vasculitis and as manifestations of primary biliary cirrhosis, can be detected as extra-intestinal pathologies [119].

Fig. 20
figure 20

Small bowel obstruction in a 31-year-old female with known scleroderma presenting with generalized abdominal pain, nausea, and vomiting without previous Hx of surgery. Axial view of CTE shows extensive cutaneous and subcutaneous calcifications (thick white arrows). Short segment benign-looking stricture (white arrowhead) is seen at the distal ileum in the pelvis, leading to upstream small bowel dilatation (white asterisks). Following segmental resection and anastomosis, this was confirmed to be a fibrotic stricture. Collapsed ileum distal to stricture is also depicted (thick black arrow)

Rheumatoid arthritis

Rheumatoid arthritis-associated vasculitis is extremely rare and can occur in patients with long-standing erosive rheumatoid arthritis [107]. Small- and medium-sized vessels are usually involved. GI manifestations may develop in 10–38% of patients with rheumatoid arthritis-associated vasculitis. These presentations include segmental or extensive intestinal infarction, ileal stricture [121, 122], ischemic ulcers of the intestine, and bowel perforation. Rarely other extra-intestinal findings, including hepatomegaly, intrahepatic hemorrhage, and pancreatic necrosis, can be evident [123].

Single-organ vasculitis (SOV)

This condition rarely occurs in the abdomen, and involvement of the abdominal organs is commonly part of systemic vasculitis. However, SOV in the GI tract has been reported in the stomach, small and large intestine, and most commonly appendix. Abdominal pain is the most frequent manifestation. Bowel infarction, perforation, bleeding, and solid-organ infarction are serious complications of GI SOV [124, 125]. The imaging findings include abnormalities of the corresponding arteries, intestinal wall thickening, bowel infarction, and infarcted areas within solid organs, including the spleen and liver [124].

Frequent mimickers of vasculitis on MRE/CTE

Inflammatory bowel disease (IBD)

IBD, particularly CD, is one of the mimickers of AAV or Behçet's disease. The common findings on MRE/CTE include multi-focal intestinal mural thickening, striated mural hyperenhancement, and engorgement of mesenteric vessels. The predominant involvement of the bowel mesentery in CD compared to vasculitis can be an essential discriminating factor. Other helpful clues suggestive of CD are the fibrofatty proliferation of the mesentery and pseudodiverticula formation (Fig. 21). Notably, IBD can occasionally be associated with vasculitis [126]. Therefore, in addition to the clinical presentation, endoscopic and histologic investigations may become necessary to differentiate these entities [127].

Fig. 21
figure 21

Crohn’s disease in a 23-year-old male presenting with abdominal pain and transient obstructive episodes. MRE was obtained. Axial T2-W image (A) shows multi-focal mural thickening in several segments of the ileum (thick white arrows) associated with increased mesenteric fat (white dotted ovals) separating the bowel loops. Coronal pre- and post-contrast T1-W images (B, C) demonstrate increased striated mural enhancement of the affected bowel segments (thin white arrows), more predominant on the mesenteric border. Engorgement of mesenteric vessels is depicted (white asterisks) representing comb sign. There is also pseudodiverticula formation along the antimesenteric border (white arrowheads)

Eosinophilic enteritis

There is an important controversy as to whether eosinophilic gastroenteritis is categorized as the pathogenic spectrum of hypereosinophilic syndrome or EGPA [128]. Imaging findings of eosinophilic enteritis are non-specific, with mural thickening being a common finding. Other radiologic presentations include nodularity, luminal narrowing, and inflammation in the adjacent mesentery [129]. The previous history of allergy and presence of eosinophilia are important diagnostic clues for eosinophilic enteritis. Similar to vasculitis, corticosteroid therapy results in dramatic alleviation of the signs and symptoms [130].

Graft-versus-host disease (GVHD)

GVHD is a life-threatening complication of allogeneic stem cell or bone marrow transplant (HSCT) involving multiple organ systems, including the GI tract, and frequently is associated with skin involvement. Imaging findings are commonly observed in the GI tract and hepatobiliary system and are non-specific. These include ascites, periportal edema, intestinal wall thickening, mucosal hyperenhancement, bowel dilatation, and submucosal edema, leading to a tubular featureless appearance of the small intestine, called the ribbon sign [131,132,133]. The main differential diagnoses include neutropenic enterocolitis, infectious enterocolitis, or radiation enteritis. [134]. The location and extent of bowel involvement, clinical history, laboratory findings, and stool studies may aid in distinguishing GVHD from intestinal vasculitis [132].

Segmental arterial mediolysis (SAM)

SAM is a non-atherosclerotic and non-inflammatory arteriopathy more commonly affecting middle-aged and elderly patients. It results from lysis of the smooth muscle of the vascular outer layer. Imaging findings in SAM are similar to vasculitis and include aneurysmal dilation, dissection, stenosis, occlusion, and mural thrombosis of splanchnic arteries, particularly in SMA. However, SAM typically involves only the splanchnic arteries and spares other vessels like renal arteries and mesenteric arterial bifurcations from damage (Fig. 22) [12, 135]. Normal levels of inflammatory or immune markers can also help to differentiate SAM from vasculitis.

Fig. 22
figure 22

Segmental arterial mediolysis (SAM) in a 55-year-old male presenting with epigastric pain for ten days and normal laboratory results. Axial, sagittal, and coronal images from CTE (AD) show fusiform aneurysmal dilatation of two jejunal branches of SMA associated with partial mural thrombosis (thick white arrows). Coronal CTE (E) demonstrates aneurysmal dilation and high-grade thrombosis at a jejunal branch of SMA (white arrowhead) with sparing of proximal arterial bifurcation (white dotted oval)

Infectious enteritis

Enterography is usually not able to detect infectious enteritis at the early stages. However, chronic infectious diseases, including tuberculosis and cytomegalovirus (CMV), are usually noticeable on CTE and MRE. Findings on enterography include segmental circumferential wall thickening, hyperenhancement, mural edema, and enlargement of the mesenteric lymph nodes [120, 136]. Infectious enteritis should always be considered, particularly in patients with immunodeficiency. Clinical history, laboratory data, and a trial of antibiotic therapy are helpful to confirm the diagnosis. Infectious enteritis is always a challenging differential diagnosis for intestinal vasculitis.


Angioedema is the swelling of the body following protein extravasation due to increased vascular permeability. The most common causes of angioedema include hereditary or acquired deficiency of C1-esterase inhibitor and medications, such as angiotensin-converting enzyme (ACE) inhibitors [137]. Angioedema commonly presents with cutaneous manifestations; however, in some cases, intra-abdominal involvement may occur without superficial manifestations. Patients with GI involvement commonly present with non-specific manifestations, including abdominal pain, nausea, and vomiting; therefore, imaging plays a key role in diagnosis [138]. Findings on CT include circumferential or asymmetric bowel wall thickening, mural stratification or halo sign due to submucosal edema, prominent mesenteric vessels, ascites, and hyperenhancement [137, 139]. Additionally, MR imaging shows submucosal edema. A thorough evaluation of patient and family history and review of medication usage history in addition to the assessment of complement markers can aid in the differentiation of angioedema from vasculitides [137].

Diagnostic strategy

Figure 23 presents a flowchart for inference about a potential diagnosis of intestinal vasculitis on MRE or CTE. Imaging features are often non-specific, including mural thickening, submucosal edema, mural hyper/hypoenhancement, and rarely stricture or perforation. Positive laboratory biomarkers, multi-organ involvement, and the presence of vascular abnormalities, especially in a young/middle-aged patient without evidence of atherosclerosis, raise the clinical suspicion of vasculitis. Since intestinal vasculitis often mimics CD, a careful inspection must be done searching for fistula/abscess, mesenteric fat wrapping, or dominant involvement of the adjacent mesenteric border. Moreover, rapid response to corticosteroids, acute presentation, multi-segmental involvement at unusual sites, i.e., esophagus, duodenum, and rectum, or diffuse long segmental bowel involvement without skip may also be suggestive of vasculitis. Infectious enteritis is another differential, particularly in immunocompromised patients. As a challenging issue, any suspicion of infectious enteritis may postpone life-saving treatment with corticosteroid or immunosuppressive agents in patients with vasculitis. Diagnosis of intestinal vasculitis (Fig. 24) relies on a combination of history, clinical presentation, imaging, laboratory findings, and histopathology. The radiologists need to be aware of the findings suggestive of the diagnosis of intestinal vasculitis to avoid potential missed or late diagnosis. Table 1 summarizes clinical clues and enterography findings of common vasculitides involving the GI tract.

Fig. 23
figure 23

A practical flowchart for potential diagnostic work up of intestinal vasculitis following MRE or CTE

Fig. 24
figure 24

The diagnosis of intestinal vasculitis is based on a combination of the clinical manifestation and history, imaging, laboratory, and histopathology findings

Table 1 Vasculitides with detected complications on enterography


While this review provides a comprehensive summary of imaging findings of intestinal involvement in vasculitis with the demonstrative cases, it faces several limitations. The sparse data on MRE and CTE findings of vasculitis were the major limitation of the literature, which might have affected this study. We did not identify any report in the literature about the MRE and CTE of some vasculitides, such as Takayasu arteritis, GCA, Kawasaki disease, and HSP. This review highlighted this gap in the literature warranting further investigation. Moreover, we could not include the images from a limited number of cases such as GCA, Kawasaki disease, and cryoglobulinemic vasculitis due to the very low frequency of these cases with intestinal involvement.


While gastrointestinal presentations are uncommon manifestations in vasculitis, their timely diagnosis holds immense importance. Establishing the diagnosis is hindered by the heterogeneous and non-specific manifestations of the vasculitides and usually requires a combination of clinical, imaging, laboratory, and histopathological data. MRE and CTE may be utilized in diagnostic investigations of patients presenting with GI involvement of a previously undiagnosed or diagnosed vasculitis. As previously described in detail, several key technical points on MRE/CTE protocols should be considered in these patients. In order to make the correct diagnosis, the imaging features need to be linked with the relevant clinical and laboratory data in a two-way street.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.



Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis


Angiotensin-converting enzyme


Antineutrophil cytoplasmic antibody


Crohn's disease




C-reactive protein


Computed tomography enterography


Eosinophilic granulomatosis with polyangiitis


European Society of Gastrointestinal and Abdominal Radiology


European Society of Pediatric Radiology


Erythrocyte sedimentation rate


Fibromuscular dysplasia


Giant cell arteritis




Granulomatosis with polyangiitis


Graft-versus-host disease


Henoch–Schönlein purpura


Inflammatory bowel disease




Microscopic polyangiitis


Magnetic resonance enterography


Polyarteritis nodosa


Positron emission tomography


Segmental arterial mediolysis


Systemic lupus erythematosus


Superior mesenteric artery


Single-organ vasculitis


  1. Saadoun D, Vautier M, Cacoub P (2021) Medium- and large-vessel vasculitis. Circulation 143(3):267–282

    CAS  PubMed  Article  Google Scholar 

  2. Broncano J, Vargas D, Bhalla S, Cummings KW, Raptis CA, Luna A (2018) CT and MR imaging of cardiothoracic vasculitis. Radiographics 38(4):997–1021

    PubMed  Article  Google Scholar 

  3. Konttinen YT, Rotar Z, Pettersson T, Nordstrom DC, Bacon P, Petersen J (2006) Roadmap to vasculitis. Acta Reumatol Port 31(1):15–36

    PubMed  Google Scholar 

  4. Ha HK, Lee SH, Rha SE et al (2000) Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics 20(3):779–794

    CAS  PubMed  Article  Google Scholar 

  5. Zhang X, Furth EE, Tondon R (2020) Vasculitis involving the gastrointestinal system is often incidental but critically important. Am J Clin Pathol 154(4):536–552

    PubMed  Article  Google Scholar 

  6. Soowamber M, Weizman AV, Pagnoux C (2017) Gastrointestinal aspects of vasculitides. Nat Rev Gastroenterol Hepatol 14(3):185–194

    CAS  PubMed  Article  Google Scholar 

  7. Anderson E, Gakhar N, Stull C, Caplan L (2018) Gastrointestinal and hepatic disease in vasculitis. Rheum Dis Clin North Am 44(1):1–14

    PubMed  Article  Google Scholar 

  8. Elsayes KM, Al-Hawary MM, Jagdish J, Ganesh HS, Platt JF (2010) CT enterography: principles, trends, and interpretation of findings. Radiographics 30(7):1955–1970

    PubMed  Article  Google Scholar 

  9. Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30(2):367–384

    PubMed  Article  Google Scholar 

  10. Fidler JL, Guimaraes L, Einstein DM (2009) MR Imaging of the small bowel. Radiographics 29(6):1811–1825

    PubMed  Article  Google Scholar 

  11. Pagnoux C, Seror R, Henegar C, et al. (2010) French Vasculitis Study G: clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62(2):616–626

    PubMed  Article  Google Scholar 

  12. Ghodasara N, Liddell R, Fishman EK, Johnson PT (2019) High-value multidetector CT angiography of the superior mesenteric artery: what emergency medicine physicians and interventional radiologists need to know. Radiographics 39(2):559–577

    PubMed  Article  Google Scholar 

  13. Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11

    CAS  PubMed  Article  Google Scholar 

  14. Nienhuis PH, van Praagh GD, Glaudemans AWJM, Brouwer E, Slart RHJA (2021) A review on the value of imaging in differentiating between large vessel vasculitis and atherosclerosis. J Pers Med 11(3):779–794

    Article  Google Scholar 

  15. Taylor SA, Avni F, Cronin CG et al (2017) The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging. Eur Radiol 27(6):2570–2582

    CAS  PubMed  Article  Google Scholar 

  16. Kanasaki S, Furukawa A, Fumoto K, et al. (2018) Acute mesenteric ischemia: multidetector CT findings and endovascular management. Radiographics 38(3):945–961

    PubMed  Article  Google Scholar 

  17. Furukawa A, Kanasaki S, Kono N, et al. (2009) CT diagnosis of acute mesenteric ischemia from various causes. AJR Am J Roentgenol 192(2):408–416

    PubMed  Article  Google Scholar 

  18. Nastri MV, Baptista LP, Baroni RH, et al. (2004) Gadolinium-enhanced three-dimensional MR angiography of Takayasu arteritis. Radiographics 24(3):773–786

    PubMed  Article  Google Scholar 

  19. Litmanovich DE, Yıldırım A, Bankier AA (2012) Insights into imaging of aortitis. Insights Imaging 3(6):545–560

    PubMed  PubMed Central  Article  Google Scholar 

  20. Chung SY, Ha HK, Kim JH et al (2001) Radiologic findings of Behçet syndrome involving the gastrointestinal tract. Radiographics 21(4):911–924

    CAS  PubMed  Article  Google Scholar 

  21. Davarpanah AH, Ghamari Khameneh A, Khosravi B, Mir A, Saffar H, Radmard AR (2021) Many faces of acute bowel ischemia: overview of radiologic staging. Insights Imaging 12(1):56

    PubMed  PubMed Central  Article  Google Scholar 

  22. Sugi MD, Menias CO, Lubner MG, et al. (2018) CT findings of acute small-bowel entities. Radiographics 38(5):1352–1369

    PubMed  Article  Google Scholar 

  23. de Souza AW, de Carvalho JF (2014) Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun 48–49:79–83

    PubMed  Article  CAS  Google Scholar 

  24. Spira D, Kötter I, Ernemann U, et al. (2010) Imaging of primary and secondary inflammatory diseases involving large and medium-sized vessels and their potential mimics: a multitechnique approach. AJR Am J Roentgenol 194(3):848–856

    PubMed  Article  Google Scholar 

  25. Schmidt J, Kermani TA, Bacani AK, et al. (2013) Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc 88(8):822–830

    PubMed  Article  Google Scholar 

  26. Koster MJ, Warrington KJ (2017) Vasculitis of the mesenteric circulation. Best Pract Res Clin Gastroenterol 31(1):85–96

    PubMed  Article  Google Scholar 

  27. Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ (2015) Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they? Semin Arthritis Rheum 44(6):724–728

    PubMed  Article  Google Scholar 

  28. Meryem E, Hatim E, Sergio EC, Khadija BEH, Ittimade N, Nabil MB (2020) Chronic dissection of the abdominal aorta as a rare complication of Takayasu disease. Radiol Case Rep 15(11):2188–2191

    PubMed  PubMed Central  Article  Google Scholar 

  29. Kilic L, Kalyoncu U, Karadag O, et al. (2016) Inflammatory bowel diseases and Takayasu’s arteritis: coincidence or association? Int J Rheum Dis 19(8):814–818

    CAS  PubMed  Article  Google Scholar 

  30. Terao C, Matsumura T, Yoshifuji H et al (2015) Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol 67(8):2226–2232

    PubMed  Article  Google Scholar 

  31. Hur JH, Chun EJ, Kwag HJ, et al. (2017) CT features of vasculitides based on the 2012 International Chapel Hill Consensus Conference Revised Classification. Korean J Radiol 18(5):786–798

    PubMed  PubMed Central  Article  Google Scholar 

  32. Gotway MB, Araoz PA, Macedo TA, et al. (2005) Imaging findings in Takayasu’s arteritis. AJR Am J Roentgenol 184(6):1945–1950

    PubMed  Article  Google Scholar 

  33. Khandelwal N, Kalra N, Garg MK, et al. (2011) Multidetector CT angiography in Takayasu arteritis. Eur J Radiol 77(2):369–374

    PubMed  Article  Google Scholar 

  34. Younger DS (2019) Giant cell arteritis. Neurol Clin 37(2):335–344

    PubMed  Article  Google Scholar 

  35. Gribbons KB, Ponte C, Carette S et al (2020) Patterns of arterial disease in Takayasu arteritis and giant cell arteritis. Arthritis Care Res (Hoboken) 72(11):1615–1624

    Article  Google Scholar 

  36. Annamalai A, Francis ML, Ranatunga SK, Resch DS (2007) Giant cell arteritis presenting as small bowel infarction. J Gen Intern Med 22(1):140–144

    PubMed  PubMed Central  Article  Google Scholar 

  37. Trimble MA, Weisz MA (2002) Infarction of the sigmoid colon secondary to giant cell arteritis. Rheumatology 41(1):108–110

    CAS  PubMed  Article  Google Scholar 

  38. Espitia O, Blonz G, Urbanski G et al (2021) Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event. Arthritis Res Ther 23(1):14

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. Jud P, Verheyen N, Dejaco C et al (2020) Prevalence and prognostic factors for aortic dilatation in giant cell arteritis – a longitudinal study. Semin Arthritis Rheum 51(4):911–918

    PubMed  Article  Google Scholar 

  40. Restrepo CS, Ocazionez D, Suri R, Vargas D (2011) Aortitis: imaging spectrum of the infectious and inflammatory conditions of the aorta. Radiographics 31(2):435–451

    PubMed  Article  Google Scholar 

  41. Stanson AW, Friese JL, Johnson CM, et al. (2001) Polyarteritis nodosa: spectrum of angiographic findings. Radiographics 21(1):151–159

    CAS  PubMed  Article  Google Scholar 

  42. Hekali P, Kajander H, Pajari R, Stenman S, Somer T (1991) Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol 32(2):143–148

    CAS  PubMed  Article  Google Scholar 

  43. Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC (2014) Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48–49:84–89

    PubMed  Article  CAS  Google Scholar 

  44. Guggenberger KV, Bley TA (2020) Imaging in vasculitis. Curr Rheumatol Rep 22(8):34

    PubMed  PubMed Central  Article  Google Scholar 

  45. Harada M, Yoshida H, Ikeda H et al (1999) Polyarthritis nodosa with mesenteric aneurysms demonstrated by angiography: report of a case and successful treatment of the patient with prednisolone and cyclophosphamide. J Gastroenterol 34(6):702–705

    CAS  PubMed  Article  Google Scholar 

  46. Pagnoux C, Mahr A, Cohen P, Guillevin L (2005) Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 84(2):115–128

    Article  Google Scholar 

  47. Passam FH, Diamantis ID, Perisinaki G, et al. (2004) Intestinal ischemia as the first manifestation of vasculitis. Semin Arthritis Rheum 34(1):431–441

    PubMed  Article  Google Scholar 

  48. Weinrich JM, Lenz A, Adam G, Francois CJ, Bannas P (2020) Radiologic imaging in large and medium vessel vasculitis. Radiol Clin North Am 58(4):765–779

    PubMed  Article  Google Scholar 

  49. Jee KN, Ha HK, Lee IJ et al (2000) Radiologic findings of abdominal polyarteritis nodosa. AJR Am J Roentgenol 174(6):1675–1679

    CAS  PubMed  Article  Google Scholar 

  50. Ozaki K, Miyayama S, Ushiogi Y, Matsui O (2009) Renal involvement of polyarteritis nodosa: CT and MR findings. Abdom Imaging 34(2):265–270

    PubMed  Article  Google Scholar 

  51. Naeem M, Menias CO, Cail AJ, et al. (2021) Imaging spectrum of granulomatous diseases of the abdomen and pelvis. Radiographics 41(3):783–801

    PubMed  Article  Google Scholar 

  52. Fabi M, Corinaldesi E, Pierantoni L et al (2018) Gastrointestinal presentation of Kawasaki disease: a red flag for severe disease? PLoS One 13(9):e0202658

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  53. Colomba C, La Placa S, Saporito L, et al. (2018) Intestinal involvement in Kawasaki disease. J Pediatr 202:186–193

    PubMed  Article  Google Scholar 

  54. Duarte R, Cisneros S, Fernandez G et al (2010) Kawasaki disease: a review with emphasis on cardiovascular complications. Insights Imaging 1(4):223–231

    PubMed  PubMed Central  Article  Google Scholar 

  55. Fraison JB, Seve P, Dauphin C et al (2016) Kawasaki disease in adults: observations in France and literature review. Autoimmun Rev 15(3):242–249

    PubMed  Article  Google Scholar 

  56. Singhal M, Gupta P, Sharma A (2019) Imaging in small and medium vessel vasculitis. Int J Rheum Dis 22(Suppl 1):78–85

    PubMed  Article  Google Scholar 

  57. Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337(21):1512–1523

    CAS  PubMed  Article  Google Scholar 

  58. Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14-22

    CAS  PubMed  Article  Google Scholar 

  59. Hunter RW, Welsh N, Farrah TE, Gallacher PJ, Dhaun N (2020) ANCA associated vasculitis. BMJ 369:m1070

    PubMed  PubMed Central  Article  Google Scholar 

  60. Comarmond C, Cacoub P (2014) Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev 13(11):1121–1125

    PubMed  Article  Google Scholar 

  61. Ananthakrishnan L, Sharma N, Kanne JP (2009) Wegener’s granulomatosis in the chest: high-resolution CT findings. AJR Am J Roentgenol 192(3):676–682

    PubMed  Article  Google Scholar 

  62. Storesund B, Gran JT, Koldingsnes W (1998) Severe intestinal involvement in Wegener’s granulomatosis: report of two cases and review of the literature. Br J Rheumatol 37(4):387–390

    CAS  PubMed  Article  Google Scholar 

  63. Sato H, Shima K, Sakata H, Ohtoh T (2019) Granulomatosis with polyangiitis with intestinal involvement successfully treated with rituximab and surgery. BMJ Case Rep 12(8):e230355

    PubMed  PubMed Central  Article  Google Scholar 

  64. Yildirim AC, Koçak E, Yildiz P, et al. (2010) Multiple intestinal perforation in a patient with Wegener’s granulomatosis: a case report and review of the literature. Gastroenterol Clin Biol 34(12):712–715

    CAS  PubMed  Article  Google Scholar 

  65. Hokama A, Kishimoto K, Ihama Y et al (2012) Endoscopic and radiographic features of gastrointestinal involvement in vasculitis. World J Gastrointest Endosc 4(3):50–56

    PubMed  PubMed Central  Article  Google Scholar 

  66. Valerieva Y, Golemanov B, Tzolova N, Mitova R (2013) Pancreatic mass as an initial presentation of severe Wegener’s granulomatosis. Ann Gastroenterol 26(3):267–269

    PubMed  PubMed Central  Google Scholar 

  67. Chirinos JA, Tamariz LJ, Lopes G, et al. (2004) Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol 23(2):152–159

    PubMed  Article  Google Scholar 

  68. Greco A, De Virgilio A, Rizzo MI, et al. (2015) Microscopic polyangiitis: Advances in diagnostic and therapeutic approaches. Autoimmun Rev 14(9):837–844

    CAS  PubMed  Article  Google Scholar 

  69. Eriksson P, Segelmark M, Hallbook O (2018) Frequency, diagnosis, treatment, and outcome of gastrointestinal disease in granulomatosis with polyangiitis and microscopic polyangiitis. J Rheumatol 45(4):529–537

    PubMed  Article  Google Scholar 

  70. Fukushima M, Inoue S, Ono Y, et al. (2013) Microscopic polyangiitis complicated with ileal involvement detected by double-balloon endoscopy: a case report. BMC Gastroenterol 13:42

    PubMed  PubMed Central  Article  Google Scholar 

  71. Ueda S, Matsumoto M, Ahn T, et al. (2001) Microscopic polyangiitis complicated with massive intestinal bleeding. J Gastroenterol 36(4):264–270

    CAS  PubMed  Article  Google Scholar 

  72. Trivioli G, Terrier B, Vaglio A. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management. Rheumatology (Oxford) 2020, 59(Suppl 3):iii84–iii94.

  73. Harada M, Oe S, Shibata M, et al. (2012) Churg-Strauss syndrome manifesting as cholestasis and diagnosed by liver biopsy. Hepatol Res 42(9):940–944

    PubMed  Article  Google Scholar 

  74. Otani Y, Anzai S, Shibuya H, et al. (2003) Churg-Strauss syndrome (CSS) manifested as necrosis of fingers and toes and liver infarction. J Dermatol 30(11):810–815

    PubMed  Article  Google Scholar 

  75. Sironen RK, Seppä A, Kosma VM, Kuopio T (2010) Churg-Strauss syndrome manifested by appendicitis, cholecystitis and superficial micronodular liver lesions—an unusual clinicopathological presentation. J Clin Pathol 63(9):848

    CAS  PubMed  Article  Google Scholar 

  76. Franco DL, Ruff K, Mertz L, Lam-Himlin DM, Heigh R (2014) Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement. Case Rep Gastroenterol 8(3):329–336

    PubMed  PubMed Central  Article  Google Scholar 

  77. Vaglio A, Corradi D, Ronda N, Garini G, Buzio C (2004) Large bowel obstruction heralding Churg-Strauss syndrome. Am J Gastroenterol 99(3):562–563

    PubMed  Article  Google Scholar 

  78. Ito Y, Yoshida M, Sugiyama T, et al. (2020) Multiple ulcerations and perforation in the small intestine after steroid treatment in eosinophilic granulomatosis with polyangiitis: a case report and literature review. Cardiovasc Pathol 47:107193

    CAS  PubMed  Article  Google Scholar 

  79. Ohnuki Y, Moriya Y, Yutani S et al (2018) Eosinophilic granulomatosis with Polyangiitis (Churg-Strauss syndrome) complicated by perforation of the small intestine and cholecystitis. Intern Med 57(5):737–740

    PubMed  Article  Google Scholar 

  80. Kim Y-K, Kim CS, Moon WS, Cho B-H, Lee SY, Lee JM (2005) MRI findings of focal eosinophilic liver diseases. AJR Am J Roentgenol 184(5):1541–1548

    PubMed  Article  Google Scholar 

  81. Chung MP, Yi CA, Lee HY, Han J, Lee KS (2010) Imaging of pulmonary vasculitis. Radiology 255(2):322–341

    PubMed  Article  Google Scholar 

  82. Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B (2015) IgA vasculitis (Henoch-Shonlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev 14(7):579–585

    CAS  PubMed  Article  Google Scholar 

  83. Calvo-Rio V, Loricera J, Mata C et al (2014) Henoch-Schonlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine (Baltimore) 93(2):106–113

    Article  Google Scholar 

  84. Miniter U, Bae-Harboe YS, Powers JG, Campbell SM, Goldberg LJ (2012) Fatal Henoch-Schonlein purpura in an adult related to bowel perforation: report and review of the literature. Dermatol Online J 18(10):9

    PubMed  Google Scholar 

  85. Cui XH, Liu H, Fu L, Zhang C, Wang XD (2019) Henoch-Schonlein purpura with intussusception and hematochezia in an adult: a case report. Medicine (Baltimore) 98(36):e16981

    Article  Google Scholar 

  86. Chao HC, Kong MS, Lin SJ (2000) Hepatobiliary involvement of Henoch-Schonlein purpura in children. Acta Paediatr Taiwan 41(2):63–68

    CAS  PubMed  Google Scholar 

  87. Johnson PT, Horton KM, Fishman EK (2007) Case 127: Henoch-Schonlein Purpura. Radiology 245(3):909–913

    PubMed  Article  Google Scholar 

  88. Weissman AS, Patel VS, Mushfiq O (2020) Case of gut necrosis in adult-onset immunoglobulin a vasculitis (Henoch-Schonlein Purpura). J Investig Med High Impact Case Rep 8:2324709620925565

    PubMed  PubMed Central  Google Scholar 

  89. Nam EJ, Kim GW, Kang JW, et al. (2014) Gastrointestinal bleeding in adult patients with Henoch-Schonlein purpura. Endoscopy 46(11):981–986

    PubMed  Article  Google Scholar 

  90. Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D (2015) Cryoglobulinemia vasculitis. Am J Med 128(9):950–955

    PubMed  Article  Google Scholar 

  91. Terrier B, Carrat F, Krastinova E et al (2013) Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. Ann Rheum Dis 72(3):374–380

    PubMed  Article  Google Scholar 

  92. Ho AC, Roat MI, Venbrux A, Hellmann DB (1999) Cogan’s syndrome with refractory abdominal aortitis and mesenteric vasculitis. J Rheumatol 26(6):1404–1407

    CAS  PubMed  Google Scholar 

  93. Greco A, De Virgilio A, Ralli M, et al. (2018) Behcet’s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev 17(6):567–575

    CAS  PubMed  Article  Google Scholar 

  94. Tursen U, Gurler A, Boyvat A (2003) Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet’s disease. Int J Dermatol 42(5):346–351

    PubMed  Article  Google Scholar 

  95. Balta I, Akbay G, Kalkan G, Eksioglu M (2014) Demographic and clinical features of 521 Turkish patients with Behcet’s disease. Int J Dermatol 53(5):564–569

    PubMed  Article  Google Scholar 

  96. Hatemi I, Hatemi G, Celik AF (2018) Gastrointestinal involvement in Behcet disease. Rheum Dis Clin North Am 44(1):45–64

    PubMed  Article  Google Scholar 

  97. Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH (2013) Clinical course of intestinal Behcet’s disease during the first five years. Dig Dis Sci 58(2):496–503

    PubMed  Article  Google Scholar 

  98. Lee CR, Kim WH, Cho YS, et al. (2001) Colonoscopic findings in intestinal Behcet’s disease. Inflamm Bowel Dis 7(3):243–249

    CAS  PubMed  Article  Google Scholar 

  99. Chae EJ, Do K-H, Seo JB et al (2008) Radiologic and clinical findings of Behçet disease: comprehensive review of multisystemic involvement. Radiographics 28(5):e31

    PubMed  Article  Google Scholar 

  100. Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF (2016) Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet’s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore) 95(16):e3348

    CAS  Article  Google Scholar 

  101. Park J, Cheon JH, Park YE, et al. (2017) Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behcet’s disease. Int J Colorectal Dis 32(5):745–751

    PubMed  Article  Google Scholar 

  102. Roeyen G, Van Schil PE, Vanmaele RG et al (1997) Abdominal aortic aneurysm with lumbar vertebral erosion in Behcet’s disease. A case report and review of the literature. Eur J Vasc Endovasc Surg 13(2):242–246

    CAS  PubMed  Article  Google Scholar 

  103. Ha HK, Lee HJ, Yang SK et al (1998) Intestinal Behçet syndrome: CT features of patients with and patients without complications. Radiology 209(2):449–454

    CAS  PubMed  Article  Google Scholar 

  104. Peker E, Erden A, Erden İ, Düzgün N (2018) Intestinal Behçet disease: evaluation with MR enterography—a case-control study. AJR Am J Roentgenol 211(4):767–775

    PubMed  Article  Google Scholar 

  105. Kao L, Weyand C (2010) Vasculitis in systemic sclerosis. Int J Rheumatol 2010:385938

    PubMed  PubMed Central  Article  Google Scholar 

  106. Norden DK, Ostrov BE, Shafritz AB, Von Feldt JM (1995) Vasculitis associated with antiphospholipid syndrome. Semin Arthritis Rheum 24(4):273–281

    CAS  PubMed  Article  Google Scholar 

  107. Sharma A, Dhooria A, Aggarwal A, Rathi M, Chandran V (2016) Connective tissue disorder-associated vasculitis. Curr Rheumatol Rep 18(6):31

    PubMed  Article  CAS  Google Scholar 

  108. Barile-Fabris L, Hernandez-Cabrera MF, Barragan-Garfias JA (2014) Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep 16(9):440

    CAS  PubMed  Article  Google Scholar 

  109. Lalani TA, Kanne JP, Hatfield GA, Chen P (2004) Imaging findings in systemic lupus erythematosus. Radiographics 24(4):1069–1086

    PubMed  Article  Google Scholar 

  110. Ju JH, Min JK, Jung CK et al (2009) Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol 5(5):273–281

    PubMed  Article  Google Scholar 

  111. Mok CC (2005) Investigations and management of gastrointestinal and hepatic manifestations of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 19(5):741–766

    CAS  PubMed  Article  Google Scholar 

  112. Pasoto SG, Adriano de Oliveira Martins V, Bonfa E (2019) Sjogren’s syndrome and systemic lupus erythematosus: links and risks. Open Access Rheumatol 11:33–45

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  113. Cicero G, Blandino A, D’Angelo T, et al. (2018) Magnetic resonance enterography appraisal of lupus enteritis: a case report. Radiol Case Rep 13(5):915–919

    PubMed  PubMed Central  Article  Google Scholar 

  114. Terra C, Ramos-Andrade D, Sá-Marques I, Brito J, Caseiro-Alves F, Curvo-Semedo L (2021) Duodenal imaging on the spotlight: from A to Z. Insights Imaging 12(1):94

    PubMed  PubMed Central  Article  Google Scholar 

  115. Huang YT, Chung TW, Wang JJ (2017) Target sign in lupus enteritis. QJM Int J Med 110(4):245–246

    CAS  Google Scholar 

  116. Byun JY, Ha HK, Yu SY, et al. (1999) CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease. Radiology 211(1):203–209

    CAS  PubMed  Article  Google Scholar 

  117. Brewer BN, Kamen DL (2018) Gastrointestinal and hepatic disease in systemic lupus erythematosus. Rheum Dis Clin N Am 44(1):165–175

    Article  Google Scholar 

  118. Madani G, Katz RD, Haddock JA, Denton CP, Bell JR (2008) The role of radiology in the management of systemic sclerosis. Clin Radiol 63(9):959–967

    CAS  PubMed  Article  Google Scholar 

  119. McFarlane IM, Bhamra MS, Kreps A et al (2018) Gastrointestinal manifestations of systemic sclerosis. Rheumatology (Sunnyvale) 8(1):235

    Article  Google Scholar 

  120. Amzallag-Bellenger E, Oudjit A, Ruiz A, Cadiot G, Soyer PA, Hoeffel CC (2012) Effectiveness of MR enterography for the assessment of small-bowel diseases beyond Crohn disease. Radiographics 32(5):1423–1444

    PubMed  Article  Google Scholar 

  121. Tago M, Naito Y, Aihara H, Furukawa NE, Yamashita S (2016) Recurrent stenosis of the ileum caused by rheumatoid vasculitis. Intern Med 55(7):819–823

    CAS  PubMed  Article  Google Scholar 

  122. Kuehne SE, Gauvin GP, Shortsleeve MJ (1992) Small bowel stricture caused by rheumatoid vasculitis. Radiology 184(1):215–216

    CAS  PubMed  Article  Google Scholar 

  123. Craig E, Cappelli LC (2018) Gastrointestinal and hepatic disease in rheumatoid arthritis. Rheum Dis Clin N Am 44(1):89–111

    Article  Google Scholar 

  124. Salvarani C, Calamia KT, Crowson CS, et al. (2010) Localized vasculitis of the gastrointestinal tract: a case series. Rheumatology (Oxford) 49(7):1326–1335

    Article  Google Scholar 

  125. Martins-Martinho J, Dourado E, Khmelinskii N, Espinosa P, Ponte C (2021) Localized forms of vasculitis. Curr Rheumatol Rep 23(7):49

    PubMed  PubMed Central  Article  Google Scholar 

  126. Sy A, Khalidi N, Dehghan N et al (2016) Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature. Semin Arthritis Rheum 45(4):475–482

    PubMed  Article  Google Scholar 

  127. Keuchel M, Kurniawan N, Baltes P (2019) Small bowel ulcers: when is it not inflammatory bowel disease ? Curr Opin Gastroenterol 35(3):213–222

    PubMed  Article  Google Scholar 

  128. Groh M, Pagnoux C, Baldini C et al (2015) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 26(7):545–553

    PubMed  Article  Google Scholar 

  129. Munjal A, Al-Sabban A, Bull-Henry K (2017) Eosinophilic enteritis: a delayed diagnosis. J Investig Med High Impact Case Rep 5(4):2324709617734246

    PubMed  PubMed Central  Google Scholar 

  130. Pineton de Chambrun G, Dufour G, Tassy B et al (2018) Diagnosis, natural history and treatment of eosinophilic enteritis: a review. Curr Gastroenterol Rep 20(8):37

    PubMed  Article  Google Scholar 

  131. Mahgerefteh SY, Sosna J, Bogot N, Shapira MY, Pappo O, Bloom AI (2011) Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology 258(3):660–671

    PubMed  Article  Google Scholar 

  132. Lubner MG, Menias CO, Agrons M, et al. (2017) Imaging of abdominal and pelvic manifestations of graft-versus-host disease after hematopoietic stem cell transplant. AJR Am J Roentgenol 209(1):33–45

    PubMed  Article  Google Scholar 

  133. Hirshberg B, Myers DT (2018) The ribbon sign. Abdom Radiol (NY) 43(12):3511–3512

    Article  Google Scholar 

  134. Coy DL, Ormazabal A, Godwin JD, Lalani T (2005) Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation. Radiographics 25(2):305–317

    PubMed  Article  Google Scholar 

  135. Michael M, Widmer U, Wildermuth S, Barghorn A, Duewell S, Pfammatter T (2006) Segmental arterial mediolysis: CTA findings at presentation and follow-up. AJR Am J Roentgenol 187(6):1463–1469

    PubMed  Article  Google Scholar 

  136. Hoeffel C, Crema MD, Belkacem A, et al. (2006) Multi-detector row CT: spectrum of diseases involving the ileocecal area. Radiographics 26(5):1373–1390

    PubMed  Article  Google Scholar 

  137. Ishigami K, Averill SL, Pollard JH, McDonald JM, Sato Y (2014) Radiologic manifestations of angioedema. Insights Imaging 5(3):365–374

    PubMed  PubMed Central  Article  Google Scholar 

  138. Savino MR, Mittal PK, Miller FH (2017) MR imaging of intestinal angioedema related to angiotensin-converting enzyme inhibitors: Report of three cases and review of literature. Clin Imaging 43:122–126

    PubMed  Article  Google Scholar 

  139. De Backer AI, De Schepper AM, Vandevenne JE, Schoeters P, Michielsen P, Stevens WJ (2001) CT of angioedema of the small bowel. AJR Am J Roentgenol 176(3):649–652

    PubMed  Article  Google Scholar 

Download references



Author information

Authors and Affiliations



MA contributed to conceptualization, investigation, resources, writing—original draft, and writing—review and editing, SM was involved in conceptualization, investigation, writing—original draft, and writing—review and editing, HK, AHD, and AS contributed to conceptualization and writing—review and editing, and ARR was involved in conceptualization, investigation, resources, writing—original draft, writing—review and editing, and supervision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Amir Reza Radmard.

Ethics declarations

Ethics approval and consent to participate

The requirement of informed consent was waived by the IRB due to the retrospective nature of the study.

Consent for publication

Not applicable.

Competing interests

All authors have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Amouei, M., Momtazmanesh, S., Kavosi, H. et al. Imaging of intestinal vasculitis focusing on MR and CT enterography: a two-way street between radiologic findings and clinical data. Insights Imaging 13, 143 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Magnetic resonance enterography
  • Computed tomography enterography
  • Vasculitis
  • Intestines